SCHEMBL1312671

SCHEMBL1312671

Cc1c(C(N)=O)c(C)n(CC(=O)NCC2CCCCN2)c1C=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.33
F2 P00734 3/20 0.33
SYK P43405 3/20 0.33
DRD2 P14416 2/20 0.32
DRD3 P35462 2/20 0.32
SCN9A Q15858 1/20 0.32
LMNA P02545 2/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2D6 P10635 2/20 0.31
PBK Q96KB5 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
CACNA1F O60840 1/20 0.31
KCNA5 P22460 1/20 0.31
SLC6A2 P23975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1312670 0.84 F2 (0.34) KCNH2F2SCN9ALMNAPMP22
SCHEMBL1312777 0.84 PARP1 (0.35) KCNH2SYKLMNASMN1; SMN2NPSR1
SCHEMBL1313864 0.82 ALOX15 (0.37) F2LMNATSHRMAPK1
SCHEMBL1312800 0.72 ACKR3 (0.41) POLR1A
SCHEMBL17104265 0.70 CHRM1 (0.34) LMNATSHR
SCHEMBL1312676 0.68 DRD2 (0.36) KCNH2DRD2DRD3SCN9ALMNA
SCHEMBL1312776 0.68 HTR1A (0.31) KCNH2DRD2DRD3LMNASMN1; SMN2
SCHEMBL1312775 0.68 DRD2 (0.41) KCNH2DRD2DRD3SCN9ALMNA
SCHEMBL15244822 0.67 FDPS (0.44) KCNH2DRD2DRD3SCN9ALMNA
SCHEMBL16509282 0.67 FDPS (0.44) KCNH2DRD2DRD3SCN9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2292613-B1 DIHYDROINDOLINONE DERIVATIVES SHANGHAI INST PHARM INDUSTRY (CN) 2015-09-30 EP disclosed
US-8829039-B2 Dihydroindolinone derivatives SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2014-09-09 US disclosed
US-20110275671-A1 DIHYDROINDOLINONE DERIVATIVES Shanghai Institute of Pharmaceutical Indusrty (CN) 2011-11-10 US disclosed
EP-2292613-A1 DIHYDROINDOLINONE DERIVATIVES Shanghai Institute of Pharmaceutical Industry (CN) 2011-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275671-A1 DIHYDROINDOLINONE DERIVATIVES LCK, CDK5, ABL1 KCNH2 4539/4885F2 2871/4885SYK 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.